The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 21, 2025

Filed:

Dec. 17, 2019
Applicant:

Colgate-palmolive Company, New York, NY (US);

Inventors:

Camille Zenobia, Hampton, NJ (US);

Harsh Mahendra Trivedi, Hillsborough, NJ (US);

Ying Yang, Monmouth Junction, NJ (US);

Carlo Daep, Brooklyn, NY (US);

James Masters, Ringoes, NJ (US);

Assignee:

Colgate-Palmolive Company, New York, NY (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
G01N 33/50 (2006.01); C12N 1/20 (2006.01); G09B 23/30 (2006.01); A61K 8/27 (2006.01); A61Q 11/00 (2006.01); C12R 1/04 (2006.01); C12R 1/46 (2006.01);
U.S. Cl.
CPC ...
G01N 33/5008 (2013.01); C12N 1/20 (2013.01); G09B 23/306 (2013.01); A61K 8/27 (2013.01); A61Q 11/00 (2013.01); C12N 2513/00 (2013.01); C12N 2533/18 (2013.01); C12R 2001/04 (2021.05); C12R 2001/46 (2021.05);
Abstract

An oral biology model which comprises biofilm, oral epithelial tissue and a suspension of neutrophil-like cells in media is disclosed. The biofilm, which comprises oral bacteria, is produced by culturing oral bacteria on a solid substrate. The oral epithelial tissue may be gingival epithelial tissue to model the gingival crevice or buccal epithelial tissue to model the oral check. The suspension of neutrophil-like cells in media comprises neutrophil-like cells that are differentiated HL60 cells induced to a neutrophil-like phenotype by treatment with retinoic acid. Methods of using the oral biology model to test and compare compounds and formulations or to screen compounds and formulations for their effect on release of inflammatory signals, their effect on biofilm and oral bacteria and/or their effect on the cellular components are disclosed.


Find Patent Forward Citations

Loading…